Investors seeking to outperform the market often focus on hand-picking stocks. Selecting the right ones has proven to be a key factor in boosting wealth.
In the latest session, Basel Medical Group Ltd (NASDAQ: BMGL) closed at $1.75 down -2.78% from its previous closing price of $1.8. In other words, the price has decreased by -$2.78 from its previous closing price. On the day, 0.66 million shares were traded. BMGL stock price reached its highest trading level at $2.1496 during the session, while it also had its lowest trading level at $1.7101.
Ratios:
For a deeper understanding of Basel Medical Group Ltd’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 1.63 and its Current Ratio is at 1.64. In the meantime, Its Debt-to-Equity ratio is 0.60 whereas as Long-Term Debt/Eq ratio is at 0.00.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, BMGL now has a Market Capitalization of 32875150 and an Enterprise Value of 22973500. As of this moment, Basel’s Price-to-Earnings (P/E) ratio for their current fiscal year is 82.16. For the stock, the TTM Price-to-Sale (P/S) ratio is 4.40 while its Price-to-Book (P/B) ratio in mrq is 6.16. Its current Enterprise Value per Revenue stands at 2.293 whereas that against EBITDA is -84.803.
Stock Price History:
Over the past 52 weeks, BMGL has reached a high of $9.40, while it has fallen to a 52-week low of $0.91. The 50-Day Moving Average of the stock is -49.25%, while the 200-Day Moving Average is calculated to be -54.41%.
Shares Statistics:
For the past three months, BMGL has traded an average of 5.51M shares per day and 877950 over the past ten days. A total of 18.75M shares are outstanding, with a floating share count of 5.82M. Shares short for BMGL as of 1749772800 were 436784 with a Short Ratio of 0.08, compared to 1747267200 on 289478. Therefore, it implies a Short% of Shares Outstanding of 436784 and a Short% of Float of 5.09.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
Earnings Estimates
The consensus estimate for the next quarter is $0, with high estimates of $0 and low estimates of $0.
Analysts are recommending an EPS of between $0 and $0 for the fiscal current year, implying an average EPS of $0.
